top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
A House Veterans' Affairs subcommittee held a hearing on expanding veterans' access to psychedelic treatments, with VA officials testifying alongside experts.

House Panel Hears Case for Psychedelic Therapy for Veterans

Nov 18, 2026

Source:

Tom Angell

Marijuana Moment

A House committee took up the question of how to get more military veterans access to psychedelic-assisted treatment, and it did so with officials from the U.S. Department of Veterans Affairs in the witness chair. The hearing, titled Psychedelic-Assisted Therapies for Veterans: The Path Forward, was held on Wednesday before the House Veterans' Affairs Subcommittee on Health.

The lineup of witnesses was notable. VA officials testified alongside medical professionals and researchers, which put the agency that provides care to millions of veterans in the same room as people studying and delivering these therapies. That pairing gives lawmakers a chance to compare what the science suggests with what the department is currently doing, and to ask how quickly the gap might close.

Rep. Mariannette Miller-Meeks, an Iowa Republican, chairs the subcommittee and led the proceedings. Psychedelic therapy has drawn interest from both parties in recent years, in large part because of the mental health challenges many veterans face and the frustration some feel with existing treatment options. A hearing focused on the path forward suggests members are looking beyond whether these treatments deserve attention and toward how access could actually be built within the veterans' health system.

Hearings like this don't change policy on their own, but they shape the conversation that comes before legislation, funding decisions, and agency action. They also put on the record the views of the department that would be responsible for putting any expanded program into practice. For veterans and their families, and for advocates who have pushed for research and access, the session is another sign that psychedelic medicine is being discussed as a serious health care issue in Congress. What happens next will depend on follow-up from the committee and the VA.

Recent Reviews

bottom of page